HIMS trades flat as FTC complaint over health data sharing weighs

Traders Union
All News
Stocks
Hims & Hers slips 0.4% amid legal risk

Highlights

Hims & Hers Health stock faces elevated legal risk as the company and executives are targeted by a securities class action lawsuit after alleged data privacy violations and questionable billing practices.
Regulatory scrutiny rose with Federal Trade Commission allegations that the firm shared sensitive health data and used recurring billing models without proper consent, potentially breaching consumer protection laws.
Shares of Hims & Hers Health trade below key moving averages with persistent selling pressure, projected to fluctuate in a $26.64 to $28.78 range and a 75% probability of further downside.

Legal and regulatory risks rise after FTC and lawsuit allegations

Hims & Hers Health, Inc. and certain executives are now subject to a securities class action lawsuit after the Federal Trade Commission filed a complaint accusing the company of sharing sensitive health information with third-party advertising platforms and billing for prescriptions prior to consultation, according to Prnewswire. The complaint also alleges the firm implemented recurring subscription models without informed consumer consent, potentially violating the Restore Online Shoppers' Confidence Act (ROSCA). These developments heighten regulatory scrutiny and add material legal risks, which may intensify investor caution regarding HIMS shares.

Momentum confusion as selling bias meets key resistance zone

On the technical front, HIMS is trading below both the MA-20 at $28.14 and MA-50 at $29.01 on the hourly chart, as well as below the MA-200 at $28.38 on the daily timeframe. The Ichimoku Kijun offers immediate resistance at $28.39, while support is established at $26.64. MACD continues to show a strong sell bias, while ADX is neutral. RSI and CCI both indicate selling pressure, but Stochastic RSI is in the overbought zone, pointing to intraday divergence among oscillators. Bull/Bear Power currently favors sellers, the Awesome Oscillator is neutral, and overall technicals reveal ongoing uncertainty with modest attempts at recovery.

Further downside risk as volatility bands limit breakout odds

Looking ahead, HIMS is expected to trade within a volatility band of $26.64 to $28.78 over the next several sessions. The base scenario anticipates sideways movement inside this range, as mixed technical signals provide little directional clarity. While a breakout above $28.39 could open a bullish scenario, a drop below $26.64 would signal a possible increase in downside momentum. Based on current trends, the probability of an upward breakout is 25%, with a 75% likelihood for a downward move.

Anton Kharitonov, Traders Union expert, sees Hims & Hers Health, Inc. facing an unfavorable mix of legal headwinds and persistent technical weakness. He notes that heightened regulatory scrutiny and ongoing litigation cloud both sentiment and risk outlook for HIMS shares. Short-term recovery attempts remain uncertain as technical resistance limits upside potential. "Until HIMS clears key resistances and addresses compliance risks, I remain cautious on the stock."

Earlier, analysts noted that persistent technical weakness and legal uncertainties were maintaining downside pressure on Hims & Hers shares. The current article adds significant regulatory risk stemming from new FTC allegations, making the potential for a sustained move below support an important risk to monitor in the days ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.